Four billion dollars is a lot of money to spend without anyone making a fuss about it. One oil producer did exactly that last month, and the land it bought sits right next to the land it already drills. 

You can still buy the whole thing at roughly eight times earnings.

Healthcare

Healthcare Services Group, Inc. (NASDAQ: HCSG) has acquired NEXDINE Hospitality for $93.5 million upfront, using cash already on its balance sheet. NEXDINE is expected to contribute more than $150 million in annual revenue while retaining its brand, headquarters, and existing leadership team.

Healthcare Services Group carries a market value near $1.46 billion and trades at roughly 9.8 times trailing free cash flow.

The company generated approximately $148.5 million of free cash flow over the past year and held far more cash than debt before completing the acquisition. Management also repurchased $44.9 million of stock during the first half under a $75 million program.

The purchase price equals about 0.62 times NEXDINE’s expected annual sales. Alongside the company’s established housekeeping and dietary operations, you now have exposure to senior-living dining and hospitality services without a debt-heavy transaction.

NEXDINE Adds More Than Revenue

NEXDINE gives Healthcare Services Group a wider role inside senior-living communities, where food quality and hospitality can influence resident satisfaction and client retention. Keeping NEXDINE’s management in place should preserve its operating relationships while the parent company supplies additional scale, purchasing reach, and financial support.

Low Margins Demand Proof

NEXDINE’s profit margins were not disclosed, and additional consideration may become payable if performance targets are reached. Labor inflation, weak customer finances, or difficult integration could also reduce the expected benefit.

Before the acquisition earns a lasting place in your portfolio, management must prove that the added revenue produces dependable cash flow rather than simply making the company larger.

Enterprise Software

Teradata Corporation (NYSE: TDC) released three healthcare and life-sciences customer results that back its enterprise AI strategy with numbers. A large U.S. health system reported a 520% increase in patient engagement after using Teradata’s platform across its digital-care programs.

Another customer deployed a disease-prediction model within three days, achieving 70% accuracy when forecasting population-level disease onset up to a decade ahead. A major U.S. healthcare payer also used Teradata’s in-database AI for a time-sensitive regulatory project without moving sensitive information into outside systems.

Teradata carries a market value near $2.73 billion and trades at roughly 11 times forward earnings. Its $330 million to $350 million adjusted free-cash-flow forecast implies a yield between 12% and 13%.’

At that multiple, the stock presents you with a measurable tradeoff: weak companywide sales growth against improving margins, recurring revenue, and cash generation.

AI Is Already Reaching Production

The customer results show Teradata operating inside production systems at meaningful scale rather than supplying another experimental AI tool. Its platform helped a health system serving more than one million patients identify risks, support clinicians, and extend remote care while keeping models and data within a governed environment.

Revenue Still Needs to Catch Up

Teradata still expects third-quarter revenue to decline between 4% and 6%, and today’s customer announcement does not disclose contract values.

Legacy products, cautious technology spending, and stronger cloud competitors can keep the shares discounted. Until these deployments lift companywide sales, slow growth should limit how much capital your position can command.

Security

Clear Secure, Inc. (NYSE: YOU) gained a new route beyond airport security today after the Department of Veterans Affairs added CLEAR1 to a VA.gov access pilot. The program begins online and at six medical centers serving a federal system connected to roughly 17 million veterans. The announcement moves its commercial identity push into a broader public-service setting.

The stock has a market capitalization near $5.6 billion against $508 million of trailing free cash flow, roughly 11 times cash generation at current prices.

CLEAR also ended June with $959 million in cash and marketable securities, no outstanding debt, and $250 million remaining under its repurchase authorization.

Recent performance makes the federal expansion harder to dismiss as an experiment. Second-quarter revenue rose 26.6%, bookings increased 32.8%, and free cash flow climbed 60%, giving you a profitable identity platform whose growth is no longer confined to airport memberships.

A Federal Door Has Opened

CLEAR1 lets veterans verify their identity remotely through biometrics or receive assistance at participating medical centers. Adoption by a large federal agency can validate the platform for other government departments, while an existing Medicare.gov contract shows that management has already started building credibility beyond travel.

The Pilot Has Not Proven Its Economics

Management did not disclose the pilot’s value, duration, or potential payment structure, and the VA can decline to expand it.

Privacy regulation, government procurement delays, and competition also remain material concerns, so your risk analysis must treat federal identity revenue as an emerging opportunity rather than guaranteed growth.

Magnolia Oil & Gas (NYSE: MGY)

Magnolia drills for oil and gas in South Texas, mostly around Giddings and Karnes. It is a pretty straightforward business: pump more barrels, keep costs under control, and return cash to shareholders.

The interesting part is the WildFire deal it closed in September. Magnolia picked up a large chunk of additional acreage and significantly expanded its Giddings position, one of its core operating areas. Production should step up sharply now that the acquisition is fully reflected in quarterly numbers, and management expects meaningful cost savings from combining the assets.

The stock still trades well below its 52-week high and at a fairly modest earnings multiple, with a dividend on top. The setup is less about chasing explosive growth and more about getting paid while the acquisition does the heavy lifting.

GlobalFoundries (NASDAQ: GFS)

GlobalFoundries makes the chips that quietly keep everything from cars to medical equipment running. It is hardly the flashiest corner of the semiconductor industry, which is part of the appeal.

The stock has climbed this year but still sits well below its 52-week high. Meanwhile, the company is pushing into some interesting areas, including a new partnership with Xanadu to manufacture photonic components for quantum computing. It has also picked up government support for quantum research and is expanding capacity with Marvell.

So you get a profitable chipmaker with several longer-term growth angles that the stock does not seem to fully reflect yet. It is a little like buying the infrastructure behind the next wave instead of trying to guess which flashy gadget wins.

Crocs (NASDAQ: CROX)

Crocs has one of those products people either love or refuse to be seen wearing. Investors, apparently, have gotten over the fashion debate.

The core clog business continues to generate plenty of cash, while HeyDude remains the headache after its expensive acquisition. That problem is already well known, though, which leaves room for the stock to surprise if HeyDude can simply stop getting worse.

The valuation is still fairly low for a highly profitable consumer brand, and the stock remains below its recent high. Crocs does not need a miracle here. It needs the main business to keep humming while management figures out what to do with the problem child.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any stocks you want me to check out.

Best Regards,
—Noah Zelvis
Undervalued Edge